Interplay of SOX transcription factors and microRNAs in the brain under physiological and pathological conditionsMilena Stevanovic, Danijela Stanisavljevic Ninkovic, Marija Mojsin, Danijela Drakulic, Marija Schwirtlich2325-2334
Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegenerationRangariroyashe H.Chipika, Grainne Mulkerrin, Pierre-François Pradat, Aizuri Murad, Fabrice Ango, Cédric Raoul, Peter Bede2335-2341
Neuroinflammation as a mechanism linking hypertension with the increased risk of Alzheimer 's diseaseEkta Bajwa, Andis Klegeris2342-2346
An atypical ubiquitin ligase at the heart of neural development and programmed axon degenerationSatpal Virdee2347-2350
The endogenous progenitor response following traumatic brain injury: a target for cell therapy paradigmsAnna Badner, Brian J.Cummings2351-2354
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer 's diseaseYan-Li Zhang, Juan Wang, Zhi-Na Zhang, Qiang Su, Jun-Hong Guo2355-2363
MicroRNAs as biomarkers in glaucoma and potential therapeutic targetsBridget Martinez, Philip V.Peplow2368-2375
Neuroprotection and neuroregeneration: roles for the white matterVito Antonio Baldassarro, Agnese Stanzani, Luciana Giardino, Laura Calzà, Luca Lorenzini2376-2380
Emerging blood exosome-based biomarkers for preclinical and clinical Alzheimer 's disease: a meta-analysis and systematic reviewWei-Lin Liu, Hua-Wei Lin, Miao-Ran Lin, Yan Yu, Huan-Huan Liu, Ya-Ling Dai, Le-Wen Chen, Wei-Wei Jia, Xiao-Jun He, Xiao-Ling Li, Jing-Fang Zhu, Xie-Hua Xue, Jing Tao, Li-Dian Chen2381-2390